← All stocks

FATE THERAPEUTICS INC

FATE Net buying
CIK 0001434316 #3595 in the set updated 19 Sep 2026
Bought (120 mo)
$137.64M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$129.44M
$177.25K on a plan · $81.30M straight out of an exercise
Sold at will
$47.96M
197 of 363 sales
Net
+$8.20M
+$89.68M against sales at will

By person

23 insiders · 387 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Redmile Group, LLC entity
Director
$135.69M (9)
$2.34M (2)
+$133.35M
38,801,402
32.38%
$95.44M
+20.5%
Wolchko J Scott
President and CEO
$49.07M (80) scheduled
−$49.07M
371,248
0.3098%
$913.20K
+161.4%
TAHL CINDY
See Remarks
$28.74M (65) scheduled
−$28.74M
589,355
0.4919%
$1.45M
+1,001%
Nashat Amir
Director
$22.96M (84)
−$22.96M
11,034
0.0092%
$27.14K
−99.2%
Valamehr Bahram
President and CEO
$14.35M (55) scheduled
−$14.35M
591,815
0.4939%
$1.46M
+659.1%
Shoemaker Daniel D
Chief Scientific Officer
$6.63M (29)
−$6.63M
73,020
0.0609%
$179.61K
−29.7%
Dulac Edward J III
Chief Financial Officer
$2.88M (17) scheduled
−$2.88M
101,479
0.0847%
$249.62K
Chu Yu-Waye
Chief Medical Officer
$1.05M (16)
−$1.05M
140,676
0.1174%
$346.03K
+106.6%
RASTETTER WILLIAM H
Director
$1,000.00K (1)
+$1,000.00K
642,424
0.5362%
$1.58M
+218.5%
MENDLEIN JOHN
Director
$698.14K (2)
$1.14M (3) scheduled
−$438.15K
311,231
0.2597%
$765.57K
+110.1%
Coughlin Timothy
Director
$150.00K (1)
$32.82K (1)
+$117.17K
9,892
0.0083%
$24.33K
Plavsic Mark
Chief Technical Officer
$109.43K (2)
−$109.43K
123,705
0.1032%
$304.29K
Storgard Chris
Chief Medical Officer
$100.00K (1)
+$100.00K
46,683
0.0390%
$114.83K
+413.6%
Agarwal Shefali
Director
$36.81K (2)
−$36.81K
10,490
0.0088%
$25.80K
+1,200%
Jooss Karin
Director
$33.84K (1)
−$33.84K
9,848
0.0082%
$24.22K
Xu Yuan
Director
$24.33K (3) scheduled
−$24.33K
8,669
0.0072%
$21.32K
Powl Brian T.
Chief Commercial Officer
$18.77K (1)
−$18.77K
41,146
0.0343%
$101.21K
HERSHBERG ROBERT
Director
$15.29K (1)
−$15.29K
10,659
0.0089%
$26.22K
Bressi Jerome Charles
See Remarks
$9.27K (1)
−$9.27K
335,203
0.2798%
$824.53K
+21.4%
Adawi Kamal
Chief Financial Officer
100,000
0.0835%
$245.98K
ABBOT STEWART
Chief Development Officer
64,917
0.0542%
$159.68K
+48.0%
EPSTEIN ROBERT S
Director
36,331
0.0303%
$89.37K
Lee Michael Stewart
Director
11,331
0.0095%
$27.87K
Insider
Date
Role
Action
Shares
Price
Amount
Valamehr Bahram
4 Aug 2026
President and CEO
Sell
43,947
$2.46
$108.10K
TAHL CINDY
4 Aug 2026
See Remarks
Sell
38,800
$2.46
$95.41K
Valamehr Bahram
20 May 2026
President and CEO
Sell
28,946
$1.88
$54.48K
TAHL CINDY
20 May 2026
See Remarks
Sell
25,590
$1.88
$48.08K
TAHL CINDY
6 May 2026
See Remarks
Exercised, kept
44,444
$1.05
$46.67K
TAHL CINDY
6 May 2026
See Remarks
Exercised, kept
122,220
$1.32
$161.33K
RASTETTER WILLIAM H
5 May 2026
Director
Exercised, kept
25,000
$1.69
$42.25K
EPSTEIN ROBERT S
5 May 2026
Director
Exercised, kept
25,000
$1.69
$42.25K
Valamehr Bahram
9 Jan 2026
President and CEO
Sell
5,190
$1.07
$5.56K
TAHL CINDY
9 Jan 2026
See Remarks
Sell
10,589
$1.06
$11.28K
Valamehr Bahram
4 Aug 2025
President and CEO
Sell
14,466
$1.06
$15.40K
TAHL CINDY
4 Aug 2025
See Remarks
Sell
9,037
$1.06
$9.57K
Valamehr Bahram
10 Jan 2025
President and CEO
Sell
8,705
$1.54
$13.41K
TAHL CINDY
10 Jan 2025
See Remarks
Sell
5,654
$1.55
$8.76K
Bressi Jerome Charles
10 Jan 2025
See Remarks
Sell
5,980
$1.55
$9.27K
Redmile Group, LLC
20 Dec 2024
Director
Buy indirect
397,964
$1.68
$668.58K
Redmile Group, LLC
20 Dec 2024
Director
Sell indirect
341,633
$1.68
$573.94K
Xu Yuan
6 Aug 2024
Director
Sold on a plan
633
$4.23
$2.68K
Dulac Edward J III
4 Mar 2024
Chief Financial Officer
Sold on a plan
2,447
$7.77
$19.01K
Dulac Edward J III
29 Jan 2024
Chief Financial Officer
Sold on a plan
1,849
$5.00
$9.25K
Dulac Edward J III
9 Jan 2024
Chief Financial Officer
Sell
7,028
$4.37
$30.71K
Wolchko J Scott
9 Jan 2024
President and CEO
Sell
14,391
$4.37
$62.89K
Valamehr Bahram
9 Jan 2024
Chief R&D Officer
Sell
11,271
$4.38
$49.37K
TAHL CINDY
9 Jan 2024
General Counsel and Secretary
Sell
10,874
$4.37
$47.52K
Dulac Edward J III
2 Jan 2024
Chief Financial Officer
Sold on a plan
5,182
$3.66
$18.97K
Redmile Group, LLC
26 Dec 2023
Director
Buy indirect
44,630
$3.72
$166.02K
Dulac Edward J III
18 Dec 2023
Chief Financial Officer
Sold on a plan
1,585
$3.50
$5.55K
TAHL CINDY
9 Nov 2023
General Counsel and Secretary
Sold on a plan
24,363
$2.40
$58.47K
Dulac Edward J III
18 Aug 2023
Chief Financial Officer
Sell
4,718
$2.80
$13.21K
Xu Yuan
4 Aug 2023
Director
Sold on a plan
632
$3.71
$2.34K
Dulac Edward J III
5 Jul 2023
Chief Financial Officer
Sold on a plan
5,182
$4.83
$25.03K
Powl Brian T.
5 Jul 2023
Chief Commercial Officer
Sell
3,854
$4.87
$18.77K
Xu Yuan
14 Jun 2023
Director
Sold on a plan
3,460
$5.58
$19.31K
Redmile Group, LLC
21 Apr 2023
Director
Buy indirect
256,639
$6.18
$1.59M
Redmile Group, LLC
20 Apr 2023
Director
Buy indirect
20,000
$5.99
$119.80K
Chu Yu-Waye
18 Apr 2023
Chief Medical Officer
Sold on a plan
2,317
$6.58
$15.25K
Chu Yu-Waye
18 Apr 2023
Chief Medical Officer
Sold on a plan
215
$6.52
$1.40K
Redmile Group, LLC
14 Apr 2023
Director
Buy indirect
25,700
$6.00
$154.20K
Redmile Group, LLC
14 Apr 2023
Director
Sell indirect
302,339
$5.84
$1.77M
MENDLEIN JOHN
19 Jan 2023
Director
Exercised, kept
28,461
$1.37
$38.99K
MENDLEIN JOHN
13 Jan 2023
Director
Buy
36,631
$5.43
$198.91K
Valamehr Bahram
12 Jan 2023
Chief R&D Officer
Exercised, kept
423
$1.37
$579.51
MENDLEIN JOHN
11 Jan 2023
Director
Buy
88,048
$5.67
$499.23K
Chu Yu-Waye
10 Jan 2023
Chief Medical Officer
Sell
7,825
$5.24
$41.00K
Dulac Edward J III
10 Jan 2023
Chief Financial Officer
Sell
7,331
$5.24
$38.41K
Plavsic Mark
10 Jan 2023
Chief Technical Officer
Sell
3,418
$5.24
$17.91K
TAHL CINDY
10 Jan 2023
General Counsel and Secretary
Sell
11,553
$5.24
$60.54K
Valamehr Bahram
10 Jan 2023
Chief R&D Officer
Sell
10,917
$5.24
$57.21K
Wolchko J Scott
10 Jan 2023
President and CEO
Sell
45,907
$5.24
$240.55K
Dulac Edward J III
18 Aug 2022
Chief Financial Officer
Sell
432
$30.41
$13.14K
Dulac Edward J III
18 Aug 2022
Chief Financial Officer
Sell
4,703
$29.75
$139.91K
Wolchko J Scott
22 Jul 2022
President and CEO
Sold after exercise
620
$33.28
$20.63K
Wolchko J Scott
22 Jul 2022
President and CEO
Sold after exercise
2,703
$32.61
$88.14K
Wolchko J Scott
22 Jul 2022
President and CEO
Sold after exercise
2,923
$31.33
$91.58K
Wolchko J Scott
21 Jul 2022
President and CEO
Sold after exercise
19,171
$33.07
$633.98K
Wolchko J Scott
21 Jul 2022
President and CEO
Sold after exercise
10,829
$32.54
$352.38K
Valamehr Bahram
7 Jul 2022
Chief R&D Officer
Sold after exercise
17,158
$30.23
$518.69K
Valamehr Bahram
6 Jul 2022
Chief R&D Officer
Sold after exercise
7,842
$30.07
$235.81K
Plavsic Mark
5 Jul 2022
Chief Technical Officer
Sell
3,719
$24.61
$91.52K
Agarwal Shefali
7 Jun 2022
Director
Sell
841
$21.89
$18.41K
Agarwal Shefali
3 Jun 2022
Director
Sell
807
$22.80
$18.40K
Coughlin Timothy
3 Jun 2022
Director
Sell
1,439
$22.81
$32.82K
HERSHBERG ROBERT
3 Jun 2022
Director
Sell
672
$22.75
$15.29K
Jooss Karin
3 Jun 2022
Director
Sell
1,483
$22.82
$33.84K
MENDLEIN JOHN
3 Jun 2022
Director
Sell
1,364
$22.79
$31.09K
TAHL CINDY
1 Jun 2022
General Counsel and Secretary
Sold after exercise
25,000
$22.96
$574.00K
Wolchko J Scott
22 Apr 2022
President and CEO
Sold after exercise
838
$35.15
$29.46K
Wolchko J Scott
22 Apr 2022
President and CEO
Sold after exercise
9,162
$34.54
$316.46K
Wolchko J Scott
21 Apr 2022
President and CEO
Sold after exercise
1,003
$37.90
$38.01K
Wolchko J Scott
21 Apr 2022
President and CEO
Sold after exercise
2,220
$36.70
$81.47K
Wolchko J Scott
21 Apr 2022
President and CEO
Sold after exercise
4,062
$35.73
$145.14K
Wolchko J Scott
21 Apr 2022
President and CEO
Sold after exercise
22,715
$34.57
$785.26K
Chu Yu-Waye
19 Apr 2022
Chief Medical Officer
Sell
4,062
$35.37
$143.67K
TAHL CINDY
1 Apr 2022
General Counsel and Secretary
Sold after exercise
25,000
$38.85
$971.25K
Valamehr Bahram
14 Mar 2022
Chief R&D Officer
Sold after exercise
100
$34.04
$3.40K
Valamehr Bahram
14 Mar 2022
Chief R&D Officer
Sold after exercise
2,960
$33.30
$98.57K
Valamehr Bahram
14 Mar 2022
Chief R&D Officer
Sold after exercise
2,195
$32.49
$71.32K
Valamehr Bahram
14 Mar 2022
Chief R&D Officer
Sold after exercise
3,067
$31.66
$97.10K
Valamehr Bahram
14 Mar 2022
Chief R&D Officer
Sold after exercise
16,678
$30.36
$506.34K
MENDLEIN JOHN
10 Mar 2022
Director
Sold after exercise
12,069
$35.48
$428.21K
MENDLEIN JOHN
10 Mar 2022
Director
Sold after exercise
19,493
$34.73
$676.99K
Wolchko J Scott
21 Jan 2022
President and CEO
Sold after exercise
10,000
$38.02
$380.20K
Wolchko J Scott
20 Jan 2022
President and CEO
Sold after exercise
30,000
$40.21
$1.21M
Chu Yu-Waye
11 Jan 2022
Senior VP Clinical Development
Sell
418
$49.10
$20.52K
Chu Yu-Waye
11 Jan 2022
Senior VP Clinical Development
Sell
3,547
$48.44
$171.82K
Dulac Edward J III
11 Jan 2022
Chief Financial Officer
Sell
390
$49.16
$19.17K
Dulac Edward J III
11 Jan 2022
Chief Financial Officer
Sell
1,380
$48.25
$66.59K
Valamehr Bahram
11 Jan 2022
Chief R&D Officer
Sell
418
$49.12
$20.53K
Valamehr Bahram
11 Jan 2022
Chief R&D Officer
Sell
4,152
$48.44
$201.12K
TAHL CINDY
11 Jan 2022
General Counsel and Secretary
Sell
536
$49.15
$26.34K
TAHL CINDY
11 Jan 2022
General Counsel and Secretary
Sell
4,883
$48.46
$236.63K
Wolchko J Scott
11 Jan 2022
President and CEO
Sell
4,519
$49.07
$221.75K
Wolchko J Scott
11 Jan 2022
President and CEO
Sell
10,047
$48.50
$487.28K
Valamehr Bahram
10 Jan 2022
Chief R&D Officer
Sell
351
$47.17
$16.56K
Valamehr Bahram
10 Jan 2022
Chief R&D Officer
Sell
5,245
$46.33
$243.00K
TAHL CINDY
10 Jan 2022
General Counsel and Secretary
Sell
643
$47.15
$30.32K
TAHL CINDY
10 Jan 2022
General Counsel and Secretary
Sell
7,095
$46.37
$329.00K
Wolchko J Scott
10 Jan 2022
President and CEO
Sell
101
$47.72
$4.82K
Wolchko J Scott
10 Jan 2022
President and CEO
Sell
20,894
$47.17
$985.57K
Wolchko J Scott
10 Jan 2022
President and CEO
Sell
13,161
$46.36
$610.14K
TAHL CINDY
3 Jan 2022
General Counsel and Secretary
Sold after exercise
861
$60.31
$51.93K
TAHL CINDY
3 Jan 2022
General Counsel and Secretary
Sold after exercise
27,812
$59.86
$1.66M
TAHL CINDY
3 Jan 2022
General Counsel and Secretary
Sold after exercise
16,900
$58.84
$994.40K
TAHL CINDY
3 Jan 2022
General Counsel and Secretary
Sold after exercise
4,427
$57.76
$255.70K
Dulac Edward J III
20 Dec 2021
Chief Financial Officer
Sold after exercise
15,977
$60.00
$958.62K
Valamehr Bahram
13 Dec 2021
Chief R&D Officer
Sold after exercise
1,600
$49.27
$78.83K
Valamehr Bahram
13 Dec 2021
Chief R&D Officer
Sold after exercise
7,718
$48.75
$376.25K
Valamehr Bahram
13 Dec 2021
Chief R&D Officer
Sold after exercise
6,564
$47.61
$312.51K
Valamehr Bahram
13 Dec 2021
Chief R&D Officer
Sold after exercise
7,018
$46.72
$327.88K
Valamehr Bahram
13 Dec 2021
Chief R&D Officer
Sold after exercise
2,100
$45.68
$95.93K
Chu Yu-Waye
10 Dec 2021
Senior VP Clinical Development
Sold after exercise
5
$55.54
$277.70
Chu Yu-Waye
10 Dec 2021
Senior VP Clinical Development
Sold after exercise
600
$54.58
$32.75K
Chu Yu-Waye
10 Dec 2021
Senior VP Clinical Development
Sold after exercise
1,031
$53.66
$55.32K
Chu Yu-Waye
10 Dec 2021
Senior VP Clinical Development
Sold after exercise
1,822
$52.37
$95.42K
Chu Yu-Waye
10 Dec 2021
Senior VP Clinical Development
Sold after exercise
1,045
$51.08
$53.38K
Chu Yu-Waye
10 Dec 2021
Senior VP Clinical Development
Sold after exercise
900
$50.42
$45.38K
Chu Yu-Waye
10 Dec 2021
Senior VP Clinical Development
Sold after exercise
2,097
$49.32
$103.42K
Wolchko J Scott
18 Nov 2021
President and CEO
Sold after exercise
20,000
$54.27
$1.09M
Wolchko J Scott
22 Oct 2021
President and CEO
Sold after exercise
30,000
$58.88
$1.77M
Wolchko J Scott
21 Oct 2021
President and CEO
Sold after exercise
14,765
$60.63
$895.20K
Wolchko J Scott
21 Oct 2021
President and CEO
Sold after exercise
15,235
$59.82
$911.36K
TAHL CINDY
1 Oct 2021
General Counsel and Secretary
Sold after exercise
11,844
$59.68
$706.86K
TAHL CINDY
1 Oct 2021
General Counsel and Secretary
Sold after exercise
21,844
$58.96
$1.29M
TAHL CINDY
1 Oct 2021
General Counsel and Secretary
Sold after exercise
16,312
$58.03
$946.63K
Dulac Edward J III
28 Sep 2021
Chief Financial Officer
Sold after exercise
19,460
$62.53
$1.22M
Valamehr Bahram
13 Sep 2021
Chief Development Officer
Sold after exercise
800
$67.46
$53.96K
Valamehr Bahram
13 Sep 2021
Chief Development Officer
Sold after exercise
8,391
$66.84
$560.88K
Valamehr Bahram
13 Sep 2021
Chief Development Officer
Sold after exercise
15,809
$65.94
$1.04M
Dulac Edward J III
19 Aug 2021
Chief Financial Officer
Sell
63
$90.00
$5.67K
Dulac Edward J III
19 Aug 2021
Chief Financial Officer
Sell
1,474
$88.65
$130.67K
Dulac Edward J III
19 Aug 2021
Chief Financial Officer
Sell
1,937
$87.90
$170.26K
Wolchko J Scott
19 Aug 2021
President and CEO
Sold after exercise
20,000
$88.01
$1.76M
Wolchko J Scott
23 Jul 2021
President and CEO
Sold after exercise
30,000
$85.28
$2.56M
Wolchko J Scott
22 Jul 2021
President and CEO
Sold after exercise
1,600
$86.90
$139.04K
Wolchko J Scott
22 Jul 2021
President and CEO
Sold after exercise
21,773
$86.19
$1.88M
Wolchko J Scott
22 Jul 2021
President and CEO
Sold after exercise
6,627
$85.38
$565.82K
TAHL CINDY
1 Jul 2021
General Counsel and Secretary
Sold after exercise
50,000
$84.56
$4.23M
TAHL CINDY
1 Jul 2021
General Counsel and Secretary
Sold after exercise
100
$95.30
$9.53K
TAHL CINDY
1 Jul 2021
General Counsel and Secretary
Sold after exercise
1,825
$94.63
$172.69K
TAHL CINDY
1 Jul 2021
General Counsel and Secretary
Sold after exercise
400
$93.31
$37.32K
TAHL CINDY
1 Jul 2021
General Counsel and Secretary
Sold after exercise
432
$92.26
$39.86K
TAHL CINDY
1 Jul 2021
General Counsel and Secretary
Sold after exercise
225
$91.06
$20.49K
TAHL CINDY
1 Jul 2021
General Counsel and Secretary
Sold after exercise
707
$90.30
$63.84K
TAHL CINDY
1 Jul 2021
General Counsel and Secretary
Sold after exercise
400
$88.93
$35.57K
TAHL CINDY
1 Jul 2021
General Counsel and Secretary
Sold after exercise
1,145
$87.90
$100.64K
TAHL CINDY
1 Jul 2021
General Counsel and Secretary
Sold after exercise
200
$86.56
$17.31K
TAHL CINDY
1 Jul 2021
General Counsel and Secretary
Sold after exercise
100
$84.83
$8.48K
Valamehr Bahram
14 Jun 2021
Chief Development Officer
Sold after exercise
400
$90.76
$36.30K
Valamehr Bahram
14 Jun 2021
Chief Development Officer
Sold after exercise
8,220
$89.68
$737.15K
Valamehr Bahram
14 Jun 2021
Chief Development Officer
Sold after exercise
16,380
$89.11
$1.46M
Wolchko J Scott
20 May 2021
President and CEO
Sold after exercise
20,000
$77.16
$1.54M
Wolchko J Scott
23 Apr 2021
President and CEO
Sold after exercise
30,000
$85.24
$2.56M
Wolchko J Scott
22 Apr 2021
President and CEO
Sold after exercise
30,000
$85.54
$2.57M
Chu Yu-Waye
16 Apr 2021
Senior VP Clinical Development
Sell
1,500
$84.41
$126.62K
Chu Yu-Waye
16 Apr 2021
Senior VP Clinical Development
Sell
900
$82.91
$74.62K
Chu Yu-Waye
16 Apr 2021
Senior VP Clinical Development
Sell
875
$81.80
$71.58K
TAHL CINDY
1 Apr 2021
See Remarks
Sold after exercise
400
$87.45
$34.98K
TAHL CINDY
1 Apr 2021
See Remarks
Sold after exercise
5,299
$86.76
$459.73K
TAHL CINDY
1 Apr 2021
See Remarks
Sold after exercise
4,835
$85.98
$415.73K
TAHL CINDY
1 Apr 2021
See Remarks
Sold after exercise
2,200
$84.48
$185.87K
TAHL CINDY
1 Apr 2021
See Remarks
Sold after exercise
3,490
$83.40
$291.08K
TAHL CINDY
1 Apr 2021
See Remarks
Sold after exercise
4,556
$82.69
$376.71K
TAHL CINDY
1 Apr 2021
See Remarks
Sold after exercise
8,220
$81.48
$669.73K
TAHL CINDY
1 Apr 2021
See Remarks
Sold after exercise
1,000
$80.49
$80.49K
Valamehr Bahram
15 Mar 2021
Chief Development Officer
Sold after exercise
1,018
$94.59
$96.30K
Valamehr Bahram
15 Mar 2021
Chief Development Officer
Sold after exercise
3,205
$93.75
$300.46K
Valamehr Bahram
15 Mar 2021
Chief Development Officer
Sold after exercise
8,404
$92.64
$778.58K
Valamehr Bahram
15 Mar 2021
Chief Development Officer
Sold after exercise
8,416
$91.94
$773.78K
Valamehr Bahram
15 Mar 2021
Chief Development Officer
Sold after exercise
3,957
$90.89
$359.65K
Shoemaker Daniel D
8 Mar 2021
Chief Scientific Officer
Sell
800
$86.70
$69.36K
Shoemaker Daniel D
8 Mar 2021
Chief Scientific Officer
Sell
2,900
$85.50
$247.96K
Shoemaker Daniel D
8 Mar 2021
Chief Scientific Officer
Sell
2,728
$84.20
$229.70K
Shoemaker Daniel D
8 Mar 2021
Chief Scientific Officer
Sell
2,480
$83.46
$206.99K
Shoemaker Daniel D
8 Mar 2021
Chief Scientific Officer
Sell
2,993
$81.60
$244.22K
Shoemaker Daniel D
8 Mar 2021
Chief Scientific Officer
Sell
5,174
$80.73
$417.72K
Shoemaker Daniel D
8 Mar 2021
Chief Scientific Officer
Sell
4,627
$79.58
$368.24K
Shoemaker Daniel D
8 Mar 2021
Chief Scientific Officer
Sell
3,298
$78.60
$259.24K
Wolchko J Scott
18 Feb 2021
President and CEO
Sold after exercise
5,547
$103.16
$572.21K
Wolchko J Scott
18 Feb 2021
President and CEO
Sold after exercise
8,602
$102.26
$879.66K
Wolchko J Scott
18 Feb 2021
President and CEO
Sold after exercise
2,602
$101.42
$263.88K
Wolchko J Scott
18 Feb 2021
President and CEO
Sold after exercise
1,848
$100.48
$185.69K
Wolchko J Scott
18 Feb 2021
President and CEO
Sold after exercise
1,401
$99.08
$138.82K
Wolchko J Scott
22 Jan 2021
President and CEO
Sold after exercise
3,075
$100.01
$307.54K
Wolchko J Scott
22 Jan 2021
President and CEO
Sold after exercise
6,520
$99.35
$647.73K
Wolchko J Scott
22 Jan 2021
President and CEO
Sold after exercise
7,638
$98.45
$751.95K
Wolchko J Scott
22 Jan 2021
President and CEO
Sold after exercise
12,767
$97.23
$1.24M
Wolchko J Scott
21 Jan 2021
President and CEO
Sold after exercise
200
$106.96
$21.39K
Wolchko J Scott
21 Jan 2021
President and CEO
Sold after exercise
645
$106.03
$68.39K
Wolchko J Scott
21 Jan 2021
President and CEO
Sold after exercise
4,271
$105.25
$449.52K
Wolchko J Scott
21 Jan 2021
President and CEO
Sold after exercise
9,156
$104.13
$953.44K
Wolchko J Scott
21 Jan 2021
President and CEO
Sold after exercise
3,895
$103.23
$402.09K
Wolchko J Scott
21 Jan 2021
President and CEO
Sold after exercise
3,300
$101.91
$336.31K
Wolchko J Scott
21 Jan 2021
President and CEO
Sold after exercise
5,993
$101.09
$605.81K
Wolchko J Scott
21 Jan 2021
President and CEO
Sold after exercise
2,540
$100.16
$254.41K
TAHL CINDY
19 Jan 2021
General Counsel and Secretary
Sold after exercise
200
$117.07
$23.41K
TAHL CINDY
19 Jan 2021
General Counsel and Secretary
Sold after exercise
4,021
$115.97
$466.33K
TAHL CINDY
19 Jan 2021
General Counsel and Secretary
Sold after exercise
14,944
$115.09
$1.72M
TAHL CINDY
19 Jan 2021
General Counsel and Secretary
Sold after exercise
15,835
$114.11
$1.81M
Shoemaker Daniel D
11 Jan 2021
Chief Scientific Officer
Sell
871
$109.65
$95.51K
Shoemaker Daniel D
11 Jan 2021
Chief Scientific Officer
Sell
1,050
$110.76
$116.30K
Shoemaker Daniel D
11 Jan 2021
Chief Scientific Officer
Sell
1,332
$111.62
$148.67K
TAHL CINDY
11 Jan 2021
General Counsel and Secretary
Sell
872
$109.65
$95.62K
TAHL CINDY
11 Jan 2021
General Counsel and Secretary
Sell
1,050
$110.76
$116.30K
TAHL CINDY
11 Jan 2021
General Counsel and Secretary
Sell
1,332
$111.62
$148.67K
Valamehr Bahram
11 Jan 2021
Chief Development Officer
Sell
871
$109.65
$95.51K
Valamehr Bahram
11 Jan 2021
Chief Development Officer
Sell
1,051
$110.76
$116.41K
Valamehr Bahram
11 Jan 2021
Chief Development Officer
Sell
1,332
$111.62
$148.67K
Wolchko J Scott
11 Jan 2021
President and CEO
Sell
2,300
$109.65
$252.20K
Wolchko J Scott
11 Jan 2021
President and CEO
Sell
2,772
$110.76
$307.02K
Wolchko J Scott
11 Jan 2021
President and CEO
Sell
3,515
$111.62
$392.33K
Redmile Group, LLC
8 Jan 2021
Director
Buy indirect
327,485
$85.50
$28.00M
Shoemaker Daniel D
8 Jan 2021
Chief Scientific Officer
Sell
151
$114.76
$17.33K
Shoemaker Daniel D
8 Jan 2021
Chief Scientific Officer
Sell
872
$115.80
$100.98K
Shoemaker Daniel D
8 Jan 2021
Chief Scientific Officer
Sell
2,451
$117.15
$287.14K
Shoemaker Daniel D
8 Jan 2021
Chief Scientific Officer
Sell
2,755
$117.60
$323.99K
TAHL CINDY
8 Jan 2021
General Counsel and Secretary
Sell
151
$114.76
$17.33K
TAHL CINDY
8 Jan 2021
General Counsel and Secretary
Sell
872
$115.80
$100.98K
TAHL CINDY
8 Jan 2021
General Counsel and Secretary
Sell
2,451
$117.15
$287.14K
TAHL CINDY
8 Jan 2021
General Counsel and Secretary
Sell
2,755
$117.60
$323.99K
Valamehr Bahram
8 Jan 2021
Chief Development Officer
Sell
151
$114.76
$17.33K
Valamehr Bahram
8 Jan 2021
Chief Development Officer
Sell
872
$115.80
$100.98K
Valamehr Bahram
8 Jan 2021
Chief Development Officer
Sell
2,451
$117.15
$287.14K
Valamehr Bahram
8 Jan 2021
Chief Development Officer
Sell
2,756
$117.60
$324.10K
Wolchko J Scott
8 Jan 2021
President and CEO
Sell
1,469
$114.76
$168.58K
Wolchko J Scott
8 Jan 2021
President and CEO
Sell
8,515
$115.80
$986.03K
Wolchko J Scott
8 Jan 2021
President and CEO
Sell
23,932
$117.15
$2.80M
Wolchko J Scott
8 Jan 2021
President and CEO
Sell
26,904
$117.60
$3.16M
Wolchko J Scott
17 Dec 2020
President and CEO
Sold after exercise
100
$93.44
$9.34K
Wolchko J Scott
17 Dec 2020
President and CEO
Sold after exercise
2,796
$92.94
$259.87K
Wolchko J Scott
17 Dec 2020
President and CEO
Sold after exercise
13,936
$91.77
$1.28M
Wolchko J Scott
17 Dec 2020
President and CEO
Sold after exercise
3,168
$90.98
$288.23K
Valamehr Bahram
14 Dec 2020
Chief Development Officer
Sold after exercise
100
$102.75
$10.28K
Valamehr Bahram
14 Dec 2020
Chief Development Officer
Sold after exercise
1,006
$102.06
$102.68K
Valamehr Bahram
14 Dec 2020
Chief Development Officer
Sold after exercise
400
$100.97
$40.39K
Valamehr Bahram
14 Dec 2020
Chief Development Officer
Sold after exercise
3,822
$99.77
$381.32K
Valamehr Bahram
14 Dec 2020
Chief Development Officer
Sold after exercise
3,148
$98.80
$311.01K
Valamehr Bahram
14 Dec 2020
Chief Development Officer
Sold after exercise
2,946
$97.70
$287.81K
Valamehr Bahram
14 Dec 2020
Chief Development Officer
Sold after exercise
11,765
$96.65
$1.14M
Valamehr Bahram
14 Dec 2020
Chief Development Officer
Sold after exercise
1,813
$95.89
$173.86K
Shoemaker Daniel D
16 Nov 2020
Chief Scientific Officer
Sell
14,781
$52.40
$774.51K
Shoemaker Daniel D
16 Nov 2020
Chief Scientific Officer
Sell
5,287
$51.60
$272.83K
Shoemaker Daniel D
16 Nov 2020
Chief Scientific Officer
Sell
4,932
$50.37
$248.41K
Wolchko J Scott
13 Nov 2020
President and CEO
Sold after exercise
10,154
$51.03
$518.16K
Wolchko J Scott
13 Nov 2020
President and CEO
Sold after exercise
9,846
$51.03
$502.44K
Wolchko J Scott
13 Nov 2020
President and CEO
Sold after exercise
10,000
$51.03
$510.30K
Wolchko J Scott
12 Nov 2020
President and CEO
Sold after exercise
1,864
$54.47
$101.53K
Wolchko J Scott
12 Nov 2020
President and CEO
Sold after exercise
10,846
$53.98
$585.51K
Wolchko J Scott
12 Nov 2020
President and CEO
Sold after exercise
2,088
$52.66
$109.96K
Wolchko J Scott
12 Nov 2020
President and CEO
Sold after exercise
15,202
$51.61
$784.52K
TAHL CINDY
5 Nov 2020
General Counsel and Secretary
Sold after exercise
2,600
$51.15
$133.00K
Showing 250 of 387 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 298
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 21
Sales on a Rule 10b5-1 plan 11
Sales straight out of an exercise 155
Sales at will 197
Transactions with no price 0
Shares from compensation/vesting 38,862,198
Sales filed before the plan box existed 178
History held since 28 Nov 2016